Health Policy Commission

The Massachusetts Health Policy Commission (HPC) is an independent state agency that develops policy to reduce healthcare cost growth and improve the quality of patient care. MHA engages and interacts with HPC staff and commissioners alike to ensure that our members’ perspectives are heard, taken into account and included at all stages of the HPC’s research, assessment and recommendations concerning broad healthcare cost and quality goals.
A new MassHealth policy that would require prior authorizations for more than 350 medical and diagnostic services is on hold for now.
This week the state senate is expected to begin deliberations on pharmaceutical cost control legislation.
The state’s Health Policy Commission (HPC) held its annual cost trends hearing last Tuesday and Wednesday.
This conference will look at effective current strategies for improved ROI across an enterprise.
Governor Charlie Baker last Friday introduced the latest legislative proposal to reform the state’s healthcare system.
Massachusetts is seeking input on the design of a new initiative called “Moving Massachusetts Upstream” (MassUP).
The Massachusetts Health Policy Commission is holding its 2019 Health Care Cost Trends Hearing on Tuesday and Wednesday, October 22 and 23.
The HPC released preliminary data showing that there has been an increase in high-acuity discharges from Massachusetts hospitals driven by changing coding practices.
Harvard Pilgrim Health Care and Tufts Health Plan, the second- and third-largest health insurers in Massachusetts, respectively, on Wednesday announced plans to merge.
At its July 24 board meeting, the Health Policy Commission (HPC) released its final report (required by Section 130 of Chapter 47 of the Acts of 2017) on the use of third party specialty pharmacies for certain clinician-administered medications.
The Health Policy Commission released this report last week tracking hospital emergency department and inpatient use in the battle against the opioid use disorder.
Efforts are underway both in Washington and on Beacon Hill to help resolve the problem of “surprise billing.”
Last week, HPC staff presented recommendations for a legislatively mandated report on insurer-compelled “brown-bagging” and “white-bagging” of pharmaceuticals that is forthcoming later this month.
The Massachusetts House of Representatives today begins debate on the proposed FY2020 state budget, and the nearly 1,400 amendments to it that have been filed.
State and federal governments are looking into rising prescription drug prices.
The Health Policy Commission (HPC) last week voted to set the statewide healthcare cost growth benchmark for calendar year 2020 at 3.1%.
One item that stood out in the HPC’s meeting last week was the ever-increasing price of insulin.
The Health Policy Commission in coming months is scheduled to decide on whether the state’s healthcare cost growth benchmark – currently set at 3.1% – should remain at that level.
HB140 An Act Relative to Abusive Practices to Change Sexual Orientation and Gender Identity in Minors Joint Committee on Children, Families & Persons with Disabilities
The 2018 Cost Trends Report from the Health Policy Commission released last month showed the persistent growth in prescription drug spending over the state’s healthcare cost growth benchmark.

Resources

Click on the links below for easy access to important information related to state healthcare issues and advocacy.
Visit the Commonwealth of Massachusetts websites below to find information on legislative hearings and other meetings of interest to the healthcare community.
To guide your navigation of the legislative process and assist your advocacy efforts, please visit the following state websites:
MHA has also developed the following documents for your information and benefit:
  • Directory of Government Officials
  • 2016-2017/2017-2018 State Legislative Package